Evaluation of 'in vitro' activity of ceftazidime/ avibactam and ceftolozane/tazobactam against ESBL-...
Evaluation of 'in vitro' activity of ceftazidime/ avibactam and ceftolozane/tazobactam against ESBL-producing Enterobacterales isolated from intensive care units from Qatar
About this item
Full title
Author / Creator
Publisher
Muscat, Oman: Oman Medical Specialty Board
Journal title
Language
English
Formats
Publication information
Publisher
Muscat, Oman: Oman Medical Specialty Board
Subjects
More information
Scope and Contents
Contents
Objectives: Extended-spectrum beta-lactamases (ESBLs) mechanism of resistance in Enterobacterales leads to poor clinical outcomes. Ceftazidime/avibactam and ceftolozane/tazobactam are two broad-spectrum antimicrobial combinations that are effective against multidrug-resistant organisms with regional variations. This study aims to evaluate the antim...
Alternative Titles
Full title
Evaluation of 'in vitro' activity of ceftazidime/ avibactam and ceftolozane/tazobactam against ESBL-producing Enterobacterales isolated from intensive care units from Qatar
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e6af5a2e723f4320852e56814f6bb6e3
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e6af5a2e723f4320852e56814f6bb6e3
Other Identifiers
ISSN
1999-768X
E-ISSN
2070-5204
DOI
10.5001/omj.2022.89
